AzTrials
AzTrials

PeriodontitisPAPDNCT02407379

Diode Laser and SRP in Chronic Periodontitis

A study testing PAPD+SRP in people with Periodontitis, run by Odontostomatologic Laser Therapy Center, Florence, Italy at 1 site in Italy.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The purpose of this study is to compare the efficacy of photoablative and photodynamic diode laser in adjunct to scaling-root planing (PAPD+SRP) and SRP alone for the treatment of periodontitis. Read more about this study

Who is it for?
Ages 20 to 70 yearsHealthy volunteers can take part
Conditions the study is for
Periodontitis
What is being tested?
PAPD+SRP
Type of treatment
Surgery or procedure
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
24 participants
Where
1 siteItaly
Study dates
Oct 2015to 28 Aug 2018
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 20 to 70 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Periodontitis:Presence of at least two teeth with at least one site with pocket probing depth (PD) ranging from 4 to 10 mm in each upper maxillary quadrant and with bleeding on probing (BOP)
  • A minimum of five natural teeth in each studied quadrant.

Who cannot join

  • History of systemic diseases (diabetes mellitus, cancer, HIV, metabolic and endocrine diseases)
  • Pregnancy or lactation
  • Chronic high-dose steroid use
  • Previous or current radiation or immunosuppressive therapies
  • Ongoing orthodontic treatments
  • Extensive carious lesions
Show all 9Show fewer
  • Recurrent antibiotic medications during the 6 months preceding the study
  • Class III tooth mobility
  • Heavy contamination by spirochetes and fungal pathogens on tongue and oral mucosa

Trial locations and contacts

1 site in 1 country.

Italy1 site
  • Odontostomatologic laser therapy center

    Florence, 50143

Other trials in Italy

About this study

Official title: Photoablative-photodynamic (PAPD) Diode Laser Therapy Adjunctive to Scaling and Root Planing in Periodontitis

The purpose of this study is to compare the efficacy of photoablative and photodynamic diode laser in adjunct to scaling-root planing (PAPD+SRP) and SRP alone for the treatment of periodontitis.

Read the detailed description

The present study is a randomized, blinded, controlled clinical trial, which used a split-mouth design. All patients were informed individually about the nature of the proposed treatment, and informed consent forms were signed. Twenty-four patients were studied. Maxillary left or right quadrants were randomly assigned to PAPD laser treatment or sham-treatment and SRP. PAPD consisted of: i) photoablative gingival epithelium with diode laser (λ 810 nm, 1 W); ii) photodynamic treatments (4-10 weekly) with diode laser (λ 635 nm, 100 mW) and 0.3% methylene blue as photoactive antiseptic, performed after SRP. Sham-treatment was similar but with switched off laser.

Efficacy evaluations, including probing depth (PD), clinical attachment level (CAL), bleeding on probing (BOP) was performed at baseline ,1year, and year 3 using a conventional manual periodontal probe. Polymorphonuclear leukocytes (PMN), erythrocytes (RBC), damaged epithelial cells (DEC) and bacteria were assayed by cytofluorescence on gingival exfoliative samples at baseline, 6 month and 1, 3, 5 years.

Conditions
Periodontitis
Being tested
PAPD+SRP, Sham-laser +SRP
Keywords
Laser, periodontitis, scaling root planing, bacteria, PMN
Medical subject headings
Periodontitis

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • PAPD+SRPProcedure or surgery

    Photoablation of the gingival epithelium was performed with at 810 nm diode laser (1 W output power, continuous wave mode, 66.7 J/cm2, a 0.6 mm optical fiber). SRP was performed using curettes. The periodontal tissues and the dental root were rinsed with the photosensitizer agent methylene blue (0.3% w/v in water). After 5 min., the treated areas were irradiated with at 635 nm diode laser (100 mW output power, continuous wave mode, 0.6 mm optic fiber). The photodynamic treatment was repeated once weekly until normalization of the cytodiagnostic parameters (range: 4-10 applications).

  • Sham-laser +SRPProcedure or surgery

    Sham-treatment was similar to the previously described treatment but with switched off laser, followed by scaling and root planing

Study groups in NCT02407379
Study groupRoleWhat they receive
PAPD+SRP QuadrantActive comparatorThis quadrant, randomly selected in each patients, undergoes treatment with PAPD+ SRP
Receives: Procedure: PAPD+SRP
Sham-laser + SRPSham comparatorThis quadrant, randomly selected in each patients, undergoes treatment with sham-laser + SRP
Receives: Procedure: Sham-laser +SRP

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. PD

    Change in probing pocket depth

    Measured: baseline, 1 year

Secondary outcomes (4)
  1. CAL

    Change in mean attachment level

    Measured: baseline, 1 year

  2. BoP

    Change in mean bleeding on probing

    Measured: baseline, 1 year

  3. PMN, DEC, bacteria

    Change in mean additional disease markers, namely polymorphonuclear leukocytes (PMN), erythrocytes (RBC), damaged epithelial cells (DEC) and bacteria were assayed by cytofluorescence on gingival exfoliative samples.

    Measured: baseline, 1 year

  4. Patient-reported outcomes

    Individual evaluation of pain/discomfort assessed by a visual analogue score interview

    Measured: baseline, 1 year

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted3 Apr 2015 (estimated)
  2. Study startOct 2015
  3. Primary completionOct 2016
  4. Study completion28 Aug 2018

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Single group
Masking
Triple blind
Who is masked
Participant, Investigator, Outcomes assessor
Enrolment
24 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02407379
Sponsor's protocol ID
OLTC014
Acronym
PAPD
Status last verified
Aug 2018
First submitted
9 Jul 2014
Last updated
31 Aug 2018
Results posted
No
Data monitoring committee
No
Individual data sharing
No

Publications

  • Giannelli M, Materassi F, Fossi T, Lorenzini L, Bani D. Treatment of severe periodontitis with a laser and light-emitting diode (LED) procedure adjunctive to scaling and root planing: a double-blind, randomized, single-center, split-mouth clinical trial investigating its efficacy and patient-reported outcomes at 1 year. Lasers Med Sci. 2018 Jul;33(5):991-1002. doi: 10.1007/s10103-018-2441-9. Epub 2018 Jan 18.

    PubMed 29349511

Questions about this trial

What is this clinical trial studying?

A study testing PAPD+SRP in people with Periodontitis, run by Odontostomatologic Laser Therapy Center, Florence, Italy at 1 site in Italy.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 9 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 31 Aug 2018. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Italy. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

PD (time frame: baseline, 1 year). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT02407379, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 31 Aug 2018.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in